Speaker:
Stan Tokachjov, MD, Ephipany Dermatology/Mohs Surgeon- has disclosed the following financial relationships:
Misonix/Bioventus/Barco/Merck- former speaker
Castle Biosciences - Investigator/Speaker
Kerecis/Boehringer Ingelheim- Speaker
Illumisonics- Clinical Advisory Board
Speaker/Moderator:
Michael Ramsey, MD, Staff Member, Geisinger - has nothing to disclose.
Learning Objectives:
At the conclusion of this session, the participant should be able to:
- Expand and review treatment options for benign and malignant skin cancer.
- Improve clinicopathologic correlation.
- Evaluate a perioral defect and recommend a reconstructive option.
- Design a Burow's advancement flap or its analogues in the perioral area.
- Recognize and diagnose common and uncommon neutrophilic dermatoses.
- Develop and recommend a treatment plan for neutrophilic dermatoses, especially pyoderma gangrenosum.
Disclosure of Relevant Financial Relationships with/without Commercial Interests:
The Planning Committee consisting of Eric W. Hossler, MD and Ashley Hubal, PA-C have no identified disclosures.
CE Committee Member/Content Reviewers have nothing to disclose.
Tammy McCormick, RDN, LDN, CDE; Timothy Murphy, MD; Michaelyn Notz, DO and Dean Parry, RPh
Any/All relevant financial relationships have been mitigated.
Content Disclosure:
This presentation/content is HIPAA compliant.
Commercial Support for this Session
None
Session date:
03/22/2024 - 8:00am to 1:00pm EDT
Location:
Dermatology Woodbine
Danville, PA
United States
See map: Google Maps
Add to calendar:
- 5.00 AAPA Category I CME
- 5.00 AMA PRA Category 1 Credit™
- 5.00 Participation Credit